Phase Ib Dose Finding Study of ABT-199 (A-1195425.0) Plus Ibrutinib (PCI-32765) and Rituximab in Patients with Relapsed/Refractory Diffuse Large B-cell NHL (DLBCL)

Sponsor
HackensackUMC

Protocol Number
Pro00005671

To Learn More Call
201-510-0910